7.100GBp+1.43%Mkt Cap: 488.71M $P/E: —1d ago
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Pricier
1M Perf
Higher
Indicators:|
Key Statistics
Company
Market Cap488.71M $
Enterprise Value492.08M $
Revenue (TTM)62.28M $
Gross Profit31.85M $
Net Income (TTM)-43.62M $
Revenue/Share0.0120 USD
Last Price7.100 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees584
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.86
PEG—
EV/EBITDA-14.32
EV/Revenue7.90
P/S7.85
P/B71.00
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
0.000059% of range12.10
52W High12.10 GBp
52W Low0.0000 GBp
Profitability
Gross Margin53.23%
Oper. Margin-31.35%
EBITDA Margin-55.16%
Profit Margin-72.91%
ROE142.35%
ROA-59.42%
Growth
Revenue Growth6.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-30.55M $
CapEx (TTM)3.72M $
FCF Margin-42.18%
FCF Yield-5.38%
Net Debt18.12M $
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity-2.13
Current Ratio1.13
Quick Ratio0.70
Book Value/Sh0.0010 GBp
Cash/Share0.0020 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)13.00 GBp
Upside (mean)+83.1%
Target Range13.00 GBp – 13.00 GBp
# Analysts1
Ownership
Shares Out.6.33B
Float701.66M
Insiders88.42%
Institutions0.01%
Technical
SMA 509.110 (-22.1%)
SMA 2009.950 (-28.6%)
Beta0.85
S&P 52W Chg20.05%
Avg Vol (30d)255.88K
Avg Vol (10d)176.23K
Technical Indicators
RSI (14)35.4
MACD-0.6204
MACD Signal-0.6128
MACD Hist.-0.0076
BB Upper9.178 GBp
BB Middle7.823 GBp
BB Lower6.468 GBp
BB Width34.64%
ATR (14)1.029 GBp
Vol Ratio (20d)0.88x